Cargando…

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes

Studies have demonstrated the adverse effects of smoking on the risk of microvascular complications; however, few have also examined the potential mediating effects of glycemic control. Using data from the Diabetes Control and Complications Trial (DCCT 1983–1993), we describe the acute and long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braffett, Barbara H., Rice, Madeline Murguia, Young, Heather A., Lachin, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322792/ https://www.ncbi.nlm.nih.gov/pubmed/30615671 http://dx.doi.org/10.1371/journal.pone.0210367

Ejemplares similares

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2017)

Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
por: Kim, Catherine, et al.
Publicado: (2014)

Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783
por: Lachin, John M., et al.
Publicado: (2017)

Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2019)

The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus
por: Bijelic, Radojka, et al.
Publicado: (2020)

Frequency of Depression in Patients with Type 2 Diabetes Mellitus and its Relationship with Glycemic Control and Diabetic Microvascular Complications
por: Sharif, Sabira, et al.
Publicado: (2019)

DNA methylation mediates HbA1c-associated complications development in Type 1 diabetes
por: Chen, Zhuo, et al.
Publicado: (2020)

VEGF Levels in Plasma in Relation to Platelet Activation, Glycemic Control, and Microvascular Complications in Type 1 Diabetes
por: Schlingemann, Reinier O., et al.
Publicado: (2013)

Type 1 diabetes associated with other autoimmune diseases: is there any association with glycemic control and microvascular complications?
por: Campanholo, Ana Luíza, et al.
Publicado: (2015)

Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control
por: Metwalley, Kotb Abbass, et al.
Publicado: (2020)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Sun, Bao, et al.
Publicado: (2021)

Hypovitaminosis D in patients with type 2 diabetes risk factors and association with glycemic control and established microvascular complications
por: Ramírez Stieben, Luis Agustín, et al.
Publicado: (2022)

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in China
por: Liu, Guangxu, et al.
Publicado: (2020)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
por: Wessells, Hunter, et al.
Publicado: (2018)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
por: Braffett, Barbara H., et al.
Publicado: (2019)

Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657–664
por: Braffett, Barbara H., et al.
Publicado: (2019)

Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010–1016
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2021)

The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life: A 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort
por: Jacobson, Alan M., et al.
Publicado: (2013)

Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2017)

Increased Concentration of C-Reactive Protein in Obese Patients with Type 2 Diabetes Is Associated with Obesity and Presence of Diabetes but Not with Macrovascular and Microvascular Complications or Glycemic Control
por: Fronczyk, Aneta, et al.
Publicado: (2013)

Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus – a study at a tertiary care center in Delhi
por: Agarwal, Charu, et al.
Publicado: (2019)

Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)
por: Lachin, John M., et al.
Publicado: (2021)

Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Lachin, John M., et al.
Publicado: (2014)

Glycemic control and complications of type 1 diabetes among children in Tanzania
por: Najem, S., et al.
Publicado: (2020)

Factors Associated with the Uptake of Rotavirus and Pneumococcal Conjugate Vaccines among Children in Armenia: Implications for Future New Vaccine Introductions
por: Agopian, Anya, et al.
Publicado: (2023)

Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
por: Pop‐Busui, Rodica, et al.
Publicado: (2021)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Relationship of Urologic Complications With Health-Related Quality of Life and Perceived Value of Health in Men and Women With Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) Cohort
por: Jacobson, Alan M., et al.
Publicado: (2015)

Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study
por: van Wijngaarden, Rients P. T., et al.
Publicado: (2017)

Musculoskeletal Complications in Type 1 Diabetes
por: Larkin, Mary E., et al.
Publicado: (2014)

The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature
por: Da’as, Sahar I., et al.
Publicado: (2023)

Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
por: Molitch, Mark E., et al.
Publicado: (2010)

Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
por: Demirel, Fatma, et al.
Publicado: (2013)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital – A Tertiary Referral Center
por: Preechasuk, Lukana, et al.
Publicado: (2022)

Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2020)

Periodontal disease and type I diabetes mellitus: Associations with glycemic control and complications
por: Meenawat, Ajita, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cnat8oe3j2hajte41h2i4hbnuk